Effect of a Low Fat Milk Product on Lipids Profile in Dyslipidemia Subjects

Inclusion Criteria: * Chinese male or female 18 to 65 years old (inclusive). Fasting Serum TC: 5.18-6.21mmol/L (equals to 200-241 mg/dl) AND Serum TG: 1.7-5.65mmol/L (equals to 150- 500 mg/dl) for at least 1 time tested by central laboratory in the past 2 weeks prior to recruitment. * Primary dyslipidemia. * The subject demonstrates an understanding of the given information and ability to record the requested data. * Having obtained his/her informed consent Exclusion Criteria: * BMI above 32 kg/m2 ( morbid obesity). * Pregnant or lactating women or intent to get pregnant. * Menopause women on hormonal replacement therapy. * Familial hyperlipidemia. * Identified food allergy to dairy product or lactose intolerance. * Severe diseases in heart, liver, kidney or hematopoietic system before admission. * History of angina, myocardial infarction, coronary artery bypass, heart failure or other cardiovascular instability during the last 6 months. * History of diabetes, GI, renal, pulmonary, hepatic and biliary, hypothyroidism, mental disease no self-control capacity or no articulate. * Subject who are currently taking drugs that interfere with lipid profiles, including but not limited to statin, nicotinic acid, bile acid sequestrant, fibric acids, policosanol tablets. * Subject who has received any anti-hyperlipidemia medication in the past 4 weeks. * Subject who regularly takes supplements with the function of lipid reduction in the past 3 months or will take during the study (e.g. plant sterols, omega-3 fish oil, beta-glucan, nut-rich diet, soy protein, soluble oat fiber, red yeast rice or other cholesterol reducing functional ingredients). * In-patient hyperlipidemia subjects. * Alcohol \> 3 glasses wine, or 2 beers, or 1 shot hard alcohol/day. * Subject who cannot be expected to comply with the study procedures. * Subject who is currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study.